>
>
>
Healthcare Reform in the Hospital: Implications for the Pharmaceutical, Biotech, and Medical Device Industries
March 2012
An exploration of the practical implications of healthcare reform.
Even if the PPACA – or components of it – are overturned by the U.S. Supreme Court … in the words of one of our Key Opinion Leader respondents, “the hospitals have moved too far forward to go back.”
The hospital channel is among the first to feel the immediate impact of the Patient Protection and Affordable Care Act (PPACA). Changes to hospital reimbursement paradigms to reward or penalize based on quality are generating significant implications on hospital structure, operations, and policies – driving the need for new strategies and areas of focus among pharmaceutical, biotech, and device companies vying for market share in this space.
HRA’s Healthcare Reform in the Hospital provides a complete and robust research based perspective on the issues shaping the future of this market:

Research Topics
|
|
Applications
|
|
Healthcare Reform in the Hospital is powered by robust, cross-stakeholder primary market research, including the perspectives of Directors of Pharmacy, Hospital Administrators, Hospitalists, and Key Opinion Leaders from both stand-alone institutions and hospitals that are part of a system.

Search Reports

![]() |
400 Lanidex Plaza
Parsippany, NJ 07054 (973) 240-1200 |
Privacy Policy |
|
Follow @HRANews |



